Literature DB >> 17332452

Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke.

Fernando Gongora-Rivera1, Julien Labreuche, Arturo Jaramillo, Philippe Gabriel Steg, Jean-Jacques Hauw, Pierre Amarenco.   

Abstract

BACKGROUND AND
PURPOSE: Myocardial infarction (MI) is the leading cause of long-term mortality in patients with stroke, yet the prevalence of coronary atherosclerosis in these individuals is unknown. The objective of the study was to establish the prevalence of coronary atherosclerosis and MI after fatal stroke.
METHODS: Using an autopsy data bank, we studied the prevalence of coronary plaques and coronary stenoses >50% and pathologic evidence of MI in 803 consecutive autopsies of neurologic patients.
RESULTS: Coronary plaques, coronary stenoses, and MI were present in 72.4%, 37.5%, and 40.8%, respectively, of the 341 patients with stroke and in 26.8%, 10.1%, and 12.8%, respectively, of the 462 patients with other neurologic diseases (P<0.001). Two-thirds of cases of MI were clinically silent and found at autopsy. Compared with other neurologic diseases, and after adjusting for age, gender, and heart weight, the odds ratios (95% confidence intervals) of the presence of coronary plaques, coronary stenosis, and MI in stroke patients were 3.81 (2.66 to 5.46), 2.80 (1.85 to 4.25), and 2.34 (1.58 to 3.46), respectively. The frequency of coronary atherosclerosis and MI was similar between stroke subtypes. The prevalence of coronary plaques, coronary stenosis, and MI was 79.0%, 42.9%, and 46.0%, respectively, in the presence of plaques in any segment of the extracranial and intracranial brain arteries, and 50.8%, 17.9%, and 23.9%, respectively, in the absence of plaques (adjusted P<0.01). Coronary atherosclerosis was also related to the severity of atherosclerosis in any segment of the cerebral arteries (adjusted probability value for linear trend <.005).
CONCLUSIONS: Coronary atherosclerosis and MI are highly prevalent in patients who died from a stroke regardless of the etiology. They are more frequent when atherosclerosis is present in the carotid and cerebral arteries. They are also common in stroke patients with no evidence of carotid or cerebral atherosclerosis.

Entities:  

Mesh:

Year:  2007        PMID: 17332452     DOI: 10.1161/01.STR.0000260091.13729.96

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Likelihood of myocardial infarction during stroke rehabilitation preceded by cardiovascular screening and an exercise tolerance test: the Locomotor Experience Applied Post-Stroke (LEAPS) trial.

Authors:  Stephen E Nadeau; Dorian Kay Rose; Bruce Dobkin; Samuel S Wu; Yufeng E Dai; Richard Schofield; Pamela W Duncan
Journal:  Int J Stroke       Date:  2014-08-26       Impact factor: 5.266

2.  Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences.

Authors:  Ernest Palomeras Soler; Virgina Casado Ruiz
Journal:  Curr Cardiol Rev       Date:  2010-08

Review 3.  MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease.

Authors:  A J Degnan; G Gallagher; Z Teng; J Lu; Q Liu; J H Gillard
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

4.  Computerized detection of noncalcified plaques in coronary CT angiography: evaluation of topological soft gradient prescreening method and luminal analysis.

Authors:  Jun Wei; Chuan Zhou; Heang-Ping Chan; Aamer Chughtai; Prachi Agarwal; Jean Kuriakose; Lubomir Hadjiiski; Smita Patel; Ella Kazerooni
Journal:  Med Phys       Date:  2014-08       Impact factor: 4.071

5.  Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.

Authors:  Takao Hoshino; Leila Sissani; Julien Labreuche; Gregory Ducrocq; Philippa C Lavallée; Elena Meseguer; Céline Guidoux; Lucie Cabrejo; Cristina Hobeanu; Fernando Gongora-Rivera; Pierre-Jean Touboul; Philippe Gabriel Steg; Pierre Amarenco
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 6.  Blood lipids and stroke: what more can we do besides reducing low-density lipoprotein cholesterol?

Authors:  Dominique Deplanque; Pierre Amarenco
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

7.  MiR-126 Affects Brain-Heart Interaction after Cerebral Ischemic Stroke.

Authors:  Jieli Chen; Chengcheng Cui; Xiaoping Yang; Jiang Xu; Poornima Venkat; Alex Zacharek; Peng Yu; Michael Chopp
Journal:  Transl Stroke Res       Date:  2017-01-19       Impact factor: 6.829

8.  Comparison of Long-Term Clinical Outcomes after Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease with and without Prior Cerebral Infarction.

Authors:  Hisataka Sasao; Hidetoshi Fujiwara; Naruyoshi Horiuchi; Shuichi Shirasaki; Ichiro Sakai; Kazuyuki Tsuchida; Hiroshi Murai
Journal:  Ann Vasc Dis       Date:  2015-05-26

9.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

10.  Risk of a coronary event in patients after ischemic stroke or transient ischemic attack.

Authors:  Ivan Poledník; Jakub Sulzenko; Petr Widimsky
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.